MSB 3.83% $1.13 mesoblast limited

"but always deliver on what they say they will do"I had to laugh...

  1. 1,996 Posts.
    lightbulb Created with Sketch. 310
    "but always deliver on what they say they will do"
    I had to laugh at that one thanks. Maybe the ledger is upside down or you are dyslexic?

    From May2019
    Mesoblast Chief Executive Dr Silviu Itescu stated: “Initiation of our rolling BLA submission to the FDA for potential United States approval of our first product is a major corporate milestone for the Company and an exciting moment in our history. We look forward to making this therapy available assoon as possible to children with this devastating disease.”

    Jan2020
    If approved, remestemcel-L is planned to be launched in the US in 2020.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.045(3.83%)
Mkt cap ! $1.290B
Open High Low Value Volume
$1.18 $1.19 $1.12 $12.16M 10.69M

Buyers (Bids)

No. Vol. Price($)
8 50650 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.14 124897 8
View Market Depth
Last trade - 16.10pm 08/05/2024 (20 minute delay) ?
Last
$1.13
  Change
-0.045 ( 4.33 %)
Open High Low Volume
$1.17 $1.17 $1.12 1447014
Last updated 15.59pm 08/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.